Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| Yesterday 4:04 PM View:  | Fox Christine EVP, Head of U.S. Commercial | Teva Pharmaceutical Industr... (TEVA) | 20-Nov-24 | Planned Option Sale | 19,388 | $16.87 | $327,085.00 | (31%) 63.49K to 44.1K | |
| Yesterday 4:04 PM View: | Fox Christine EVP, Head of U.S. Commercial | Teva Pharmaceutical Industr... (TEVA) | 20-Nov-24 | Option Exercise | 63,492 | -- | -- | 100% 0 to 63.49K | |
| 04-Sep-24 7:40 AM View: | Shalev Varda Director | Teva Pharmaceutical Industr... (TEVA) | 02-Sep-24 | Option Exercise | 12,872 | -- | -- | 100% 0 to 12.87K | |
| 13-Aug-24 4:09 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 12-Aug-24 | Private Sale | 98,943 | $17.30 | $1,711,450.00 | (100%) 98.94K to 0 | |
| 13-Aug-24 4:02 PM View: | Hughes Eric A See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 09-Aug-24 | Private Sale | 45,060 | $17.38 | $782,972.00 | (100%) 45.06K to 0 | |
| 13-Aug-24 4:06 PM View: | Grant Angus EVP, Business Development | Teva Pharmaceutical Industr... (TEVA) | 09-Aug-24 | Planned Option Sale | 4,065 | $17.28 | $70,243.20 | (31%) 12.91K to 8.85K | |
| 13-Aug-24 4:06 PM View: | Grant Angus EVP, Business Development | Teva Pharmaceutical Industr... (TEVA) | 09-Aug-24 | Option Exercise | 12,913 | -- | -- | 100% 0 to 12.91K | |
| 05-Aug-24 7:35 AM View: | Hughes Eric A See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 01-Aug-24 | Option Exercise | 52,742 | -- | -- | 313% 16.86K to 69.6K | |
| 05-Aug-24 7:35 AM View: | Hughes Eric A See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 01-Aug-24 | Planned Option Sale | 24,537 | $17.25 | $423,280.00 | (35%) 69.6K to 45.06K | |
| 21-Jun-24 4:05 PM View: | Mignone Roberto Director | Teva Pharmaceutical Industr... (TEVA) | 18-Jun-24 | Private Sale | 519,000 | $17.03 | $8,838,570.00 | (33%) 1.6M to 1.08M | |
| 17-Jun-24 7:38 AM View: | Satchi-Fainaro Ronit Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 21,108 | -- | -- | 31% 67.17K to 88.28K | |
| 17-Jun-24 7:14 AM View: | Barer Sol J Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 37,598 | -- | -- | 10% 371.52K to 409.11K | |
| 17-Jun-24 7:23 AM View: | Vergis Janet S. Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 21,108 | -- | -- | 49% 42.96K to 64.06K | |
| 17-Jun-24 7:27 AM View: | Nisen Perry Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 21,108 | -- | -- | 28% 74.58K to 95.68K | |
| 17-Jun-24 8:00 AM View: | Mignone Roberto Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 21,108 | -- | -- | < 1% 3.07M to 3.1M | |
| 17-Jun-24 7:41 AM View: | Crane Rosemary A Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 21,108 | -- | -- | 26% 82.51K to 103.61K | |
| 17-Jun-24 8:03 AM View: | Zaks Tal Zvi Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 21,108 | -- | -- | 75% 28.03K to 49.14K | |
| 17-Jun-24 7:20 AM View: | Lieberman Gerald M Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 21,108 | -- | -- | 25% 84.92K to 106.03K | |
| 17-Jun-24 7:17 AM View: | Elstein Amir Director | Teva Pharmaceutical Industr... (TEVA) | 15-Jun-24 | Option Exercise | 21,108 | -- | -- | 1% 2.07M to 2.09M | |
| 17-May-24 7:41 AM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 16-May-24 | Sale | 12,635 | $16.65 | $210,377.00 | (71%) 17.81K to 5.18K | |
| 17-May-24 7:41 AM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 15-May-24 | Private Sale | 15,500 | $16.80 | $260,417.00 | (47%) 33.31K to 17.81K | |
| 15-May-24 8:36 AM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 13-May-24 | Private Sale | 15,219 | $16.74 | $254,807.00 | (100%) 15.22K to 0 | |
| 07-Mar-24 4:27 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 06-Mar-24 | Sale (Planned) | 3,843 | $13.52 | $51,939.70 | (2%) 207.53K to 203.69K | |
| 07-Mar-24 4:27 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 06-Mar-24 | Planned Option Sale | 73,707 | $13.52 | $996,180.00 | (26%) 281.24K to 207.53K | |
| 07-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Sale | 18,103 | $13.52 | $244,769.00 | (5%) 400.69K to 382.59K | |
| 07-Mar-24 4:20 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 77,802 | -- | -- | 112% 69.77K to 147.57K | |
| 07-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 81,897 | -- | -- | 20% 400.69K to 482.59K | |
| 07-Mar-24 4:20 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Planned Option Sale | 48,629 | $13.52 | $657,240.00 | (33%) 147.57K to 98.94K | |
| 07-Mar-24 4:27 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 73,707 | -- | -- | 36% 207.53K to 281.24K | |
| 07-Mar-24 4:24 PM View: | Drape Eric Executive VP Global Operations | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 77,802 | -- | -- | 114% 68.11K to 145.91K | |
| 07-Mar-24 4:08 PM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 3,564 | -- | -- | 12% 29.75K to 33.31K | |
| 07-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Sale | 81,897 | $13.52 | $1,107,320.00 | (17%) 482.59K to 400.69K | |
| 07-Mar-24 4:16 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Option Exercise | 4,954 | -- | -- | 42% 11.69K to 16.65K | |
| 07-Mar-24 4:16 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 05-Mar-24 | Planned Option Sale | 1,427 | $13.52 | $19,286.50 | (9%) 16.65K to 15.22K | |
| 05-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 33,512 | -- | -- | 9% 367.18K to 400.69K | |
| 05-Mar-24 4:21 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Planned Option Sale | 95,762 | $13.34 | $1,277,210.00 | (58%) 165.53K to 69.77K | |
| 05-Mar-24 4:08 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 33,512 | -- | -- | 19% 174.02K to 207.53K | |
| 05-Mar-24 4:16 PM View: | Hughes Eric A See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Planned Option Sale | 8,045 | $13.34 | $107,299.00 | (32%) 24.9K to 16.86K | |
| 05-Mar-24 4:25 PM View: | Drape Eric Executive VP Global Operations | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 33,512 | -- | -- | 75% 44.42K to 77.93K | |
| 05-Mar-24 4:03 PM View: | Weiss Amir Chief Accounting Officer | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 10,676 | -- | -- | 56% 19.07K to 29.75K | |
| 05-Mar-24 4:27 PM View: | Francis Richard D President and CEO | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Planned Option Sale | 31,061 | $13.34 | $414,270.00 | (20%) 154.36K to 123.3K | |
| 05-Mar-24 4:39 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 7,117 | -- | -- | 88% 8.11K to 15.22K | |
| 05-Mar-24 4:39 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Planned Option Sale | 3,532 | $13.37 | $47,234.50 | (23%) 15.22K to 11.69K | |
| 05-Mar-24 4:21 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 04-Mar-24 | Option Exercise | 33,512 | -- | -- | 25% 132.02K to 165.53K | |
| 05-Mar-24 4:39 PM View: | Conway Vikki L See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 5,179 | -- | -- | 177% 2.93K to 8.11K | |
| 05-Mar-24 4:21 PM View: | Daniell Richard Exec. VP, European Commercial | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 62,250 | -- | -- | 89% 69.77K to 132.02K | |
| 05-Mar-24 4:12 PM View: | Sabag Mark EVP, International Markets | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 24,900 | -- | -- | 7% 342.28K to 367.18K | |
| 05-Mar-24 4:08 PM View: | Kalif Eliyahu Sharon EVP, Chief Financial Officer | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 49,800 | -- | -- | 40% 124.22K to 174.02K | |
| 05-Mar-24 4:16 PM View: | Hughes Eric A See "Remarks" | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 24,900 | -- | -- | 100% 0 to 24.9K | |
| 05-Mar-24 4:27 PM View: | Francis Richard D President and CEO | Teva Pharmaceutical Industr... (TEVA) | 03-Mar-24 | Option Exercise | 67,231 | -- | -- | 77% 87.13K to 154.36K |
